G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy
Ozelius, Laurie J.; Foroud, Tatiana; May, Susanne; Senthil, Geetha; Sandroni, Paola; Low, Phillip A.; Reich, Stephen G.; Colcher, Amy; Stern, Matthew B.; Ondo, William G.; Jankovic, Joseph; Huang, Neng; Tanner, Caroline M.; Novak, Peter; Gilman, Sid; Marshall, Frederick J.; Wooten, G. Frederick; Chelimsky, Thomas C.; Shults, Clifford W.
2007-03-15
Citation
Ozelius, Laurie J.; Foroud, Tatiana; May, Susanne; Senthil, Geetha; Sandroni, Paola; Low, Phillip A.; Reich, Stephen; Colcher, Amy; Stern, Matthew B.; Ondo, William G.; Jankovic, Joseph; Huang, Neng; Tanner, Caroline M.; Novak, Peter; Gilman, Sid; Marshall, Frederick J.; Wooten, G. Frederick; Chelimsky, Thomas C.; Shults, Clifford W. (2007)."G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy." Movement Disorders 22(4): 546-549. <http://hdl.handle.net/2027.42/56014>
Abstract
Multiple system atrophy (MSA) is characterized clinically by Parkinsonism, cerebellar dysfunction, and autonomic impairment. Multiple mutations in the LRRK2 gene are associated with parkinsonian disorders, and the most common one, the G2019S mutation, has been found in ∼1% of sporadic cases of Parkinsonism. In a well-characterized cohort of 136 subjects with probable MSA and 110 neurologically evaluated control subjects, none carried the G2019S mutation. We conclude that the G2019S mutation in the LRRK2 gene is unlikely to be associated with MSA. © 2007 Movement Disorder SocietyPublisher
Wiley Subscription Services, Inc., A Wiley Company
ISSN
0885-3185 1531-8257
Other DOIs
PMID
17230458
Types
Article
URI
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17230458&dopt=citationMetadata
Show full item recordAccessibility: If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.